- $1.25bn
- $1.15bn
- $333.62m
- 40
- 25
- 87
- 50
Annual income statement for Ardelyx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.57 | 10.1 | 52.2 | 124 | 334 |
| Cost of Revenue | |||||
| Gross Profit | 7.43 | 9.1 | 48 | 107 | 283 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 98.4 | 164 | 116 | 188 | 362 |
| Operating Profit | -90.8 | -154 | -63.8 | -63.3 | -27.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -94.3 | -158 | -67.2 | -65.5 | -38.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -94.3 | -158 | -67.2 | -66.1 | -39.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -94.3 | -158 | -67.2 | -66.1 | -39.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -94.3 | -158 | -67.2 | -66.1 | -39.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.05 | -1.48 | -0.424 | -0.3 | -0.166 |